Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Opioid-sparing Effects of SoluMatrix Indomethacin in a Phase 3 Study in Patients With Acute Postoperative Pain.
Journal: The Clinical journal of pain
Published: June 08, 2017
SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain.
Journal: Pain medicine (Malden, Mass.)
Published: March 21, 2016
Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
Journal: Current medical research and opinion
Published: October 28, 2015
Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.
Journal: Clinical rheumatology
Published: October 12, 2015
Low-dose SoluMatrix diclofenac : a review of safety across two Phase III studies in patients with acute and osteoarthritis pain.
Journal: Expert opinion on drug safety
Published: May 26, 2015
Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.
Journal: Drugs
Published: May 13, 2015
Pharmacokinetics and safety of low-dose submicron indomethacin 20 and 40 mg compared with indomethacin 50 mg.
Journal: Postgraduate medicine
Published: February 03, 2015
Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
Journal: Current medical research and opinion
Published: July 23, 2014
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
Journal: Clinical therapeutics
Published: July 23, 2014
A phase 2 study of lower-dose, indomethacin submicron particle capsules demonstrates early onset of acute pain relief.
Journal: The Clinical journal of pain
Published: December 05, 2013
Last Updated: 09/26/2026